Patents by Inventor Guang Hai Shen

Guang Hai Shen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition comprising an extract of and tiarellic acid isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity
    Patent number: 7763286
    Abstract: The present invention relates to a composition comprising an extract of Tiarella polyphylla, and tiarellic acid isolated therefrom having anti-inflammatory, anti-allergic and anti-asthmatic activity. The extract of Tiarella polyphylla and the tiarellic acid isolated therefrom shows the inhibitory effect on the LTC4 release in vitro test and the suppressive effect on the IgE level and the cytokine (IL-4, IL-5 and IL-13) production, airway hyperresponsiveness, and leukocyte infiltration in OVA-induced asthmatic mice. Therefore, it can be used as the therapeutics or functional health food for treating and preventing inflammatory, allergic and asthmatic disease.
    Type: Grant
    Filed: July 18, 2006
    Date of Patent: July 27, 2010
    Assignee: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Hyeong Kyu Lee, Sei Ryang Oh, Kyung Seop Ahn, Joong Ku Lee, Sang Ku Lee, Jung Hee Kim, Doo Young Kim, Gui Hua Quan, Ok Kyoung Kwon, Eun Ah Kim, Soon Ja Choi, Guang Hai Shen, Mi Jin Kim, Bo Young Park, Byung Sun Min, Gyoon Hee Han, Hea Young Park, Gun Cheol Kim, Joo Heon Kim, So Young Kim
  • Composition comprising an extract of tiarella polyphylla and tiarellic acid isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity
    Publication number: 20090148542
    Abstract: The present invention relates to a composition comprising an extract of Tiarella polyphylla, and tiarellic acid isolated therefrom having anti-inflammatory, anti-allergic and anti-asthmatic activity. The extract of Tiarella polyphylla and the tiarellic acid isolated therefrom shows the inhibitory effect on the LTC4 release in vitro test and the suppressive effect on the IgE level and the cytokine (IL-4, IL-5 and IL-13) production, airway hyperresponsiveness, and leukocyte infiltration in OVA-induced asthmatic mice. Therefore, it can be used as the therapeutics or functional health food for treating and preventing inflammatory, allergic and asthmatic disease.
    Type: Application
    Filed: July 18, 2006
    Publication date: June 11, 2009
    Applicant: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Hyeong Kyu Lee, Sei Ryang Oh, Kyung Seop Ahn, Joong Ku Lee, Sang Ku Lee, Jung Hee Kim, Doo Young Kim, Gui Hua Quan, Ok Kyoung Kwon, Eun Ah Kim, Soon Ja Choi, Guang Hai Shen, Mi Jin Kim, Bo Young Park, Byung Sun Min, Gyoon Hee Han, Hea Young Park, Gun Cheol Kim, Joo Heon Kim, So Young Kim